3 results about "Daphne genkwa" patented technology

This invention discloses a topical traditional Chinese medicine powder for eliminating effusions in cavities and its preparation method, belonging to the technical field of topical traditional Chinese medicine preparations. The powder is composed of Angelica sinensis, frankincense, myrrh, dragon's blood, catechu, Notopterygium incisum, Angelica dahurica, Saposhnikovia divaricata, Daphne genkwa, Paeonia lactiflora, Evodia rutaecarpa, and cinnamon in a specific weight ratio, prepared into a dark reddish-brown powder through a purely physical crushing process. This powder is specifically designed to eliminate various types of effusions in cavities. It can effectively improve symptoms within 1-7 days after use. The formula strictly adheres to traditional Chinese medicine compatibility principles, with each component working synergistically. The topical application method avoids the gastrointestinal irritation and other adverse reactions that may occur with oral medications. The preparation process is simple and environmentally friendly, requiring no complex equipment or chemical processing steps, and retains the original activity of each herbal component, demonstrating significant practical value and promising prospects for promotion.

The invention relates to the technical field of traditional Chinese medicine, and discloses a traditional Chinese medicine ointment for treating hyperostosis and soft tissue injury and a preparation method thereof, the traditional Chinese medicine ointment is prepared by combining raw material medicines and auxiliary materials, the raw material medicines comprise knoxia root, lilac daphne flower bud, euphorbia kansui, liquorice and seaweed, and the auxiliary materials comprise oil and yellow lead. According to the external-use analgesic plaster, the euphorbia pekinensis, the lilac daphne flower bud and the euphorbia kansui have a synergistic effect, the effects of softening bone spurs of hyperosteogeny and resolving local phlegm stasis and retardation are remarkable, and compared with a conventional external-use analgesic plaster for hyperosteogeny, the external-use analgesic plaster can improve the hyperplasia state from the pathogenesis level; meanwhile, the formula is superior to a conventional safflower oil preparation in the aspects of absorption of hematoma caused by soft tissue injury and relieving speed and depth of swelling and pain caused by meridian blocking, and the recovery phase of acute injury can be shortened.

The invention belongs to the field of traditional Chinese medicine preparation, and relates to application of biflavone compounds isochamaejasmine and genkwanol A in preparation of anti-complement drugs. According to the present invention, the biflavone compounds such as the isochamaejasme and the genkwanol A are extracted from the ethyl acetate extraction part of the ethanol extract of the dried root of Stellera tianshanica plant Stellera tianshanica Pod. The in-vitro anti-complement activity evaluation experiment results prove that the biflavone compounds such as the isochamaejasme and the genkwanol A have strong inhibition effects on the classical pathway and the alternative pathway of the complement system, wherein the stellera tianshanica and the genkwanol A are extracted from the ethyl acetate extraction part of the ethanol extract of the dried root of Stellera tianshanica Pod. The biflavone compound isochamaejasmine and genkwanol A can be further used for preparing medicines for treating complement related diseases, and the complement related diseases comprise systemic lupus erythematosus, rheumatoid arthritis or acute respiratory distress syndrome.